Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Sees Unusually-High Trading Volume - What's Next?

Key Points

• Bayer Aktiengesellschaft's trading volume surged by 114% to 1,712,818 shares on Monday, with the stock currently priced at $7.88.
• Recent analyst ratings show a mixed outlook with two strong buy, one buy, and two hold ratings, contributing to an average rating of Buy.
• Bayer reported $0.65 EPS for the last quarter, surpassing estimates, with revenues hitting $15.27 billion against a forecast of $13.39 billion.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) shares saw unusually-high trading volume on Monday . Approximately 1,712,818 shares changed hands during trading, an increase of 114% from the previous session's volume of 801,543 shares.The stock last traded at $7.88 and had previously closed at $8.09.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on BAYRY. Hsbc Global Res raised shares of Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 11th. Wall Street Zen lowered Bayer Aktiengesellschaft from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. The Goldman Sachs Group upgraded Bayer Aktiengesellschaft from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Finally, Kepler Capital Markets raised Bayer Aktiengesellschaft from a "hold" rating to a "buy" rating in a report on Wednesday, June 11th. Two investment analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Buy".

Bayer Aktiengesellschaft Trading Up 0.9%

The stock has a market cap of $29.35 billion, a P/E ratio of -7.70 and a beta of 0.91. The firm's 50 day simple moving average is $7.82 and its two-hundred day simple moving average is $6.72. The company has a quick ratio of 0.79, a current ratio of 1.25 and a debt-to-equity ratio of 1.07.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.35 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.10. The business had revenue of $12.42 billion during the quarter, compared to the consensus estimate of $10.79 billion. Bayer Aktiengesellschaft had a negative net margin of 7.61% and a positive return on equity of 15.48%. As a group, equities research analysts predict that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.